Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H36N2O4 |
Molecular Weight | 452.5857 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC1=C(C=CC(CC(=O)N[C@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)=C1)C(O)=O
InChI
InChIKey=FAEKWTJYAYMJKF-HSZRJFAPSA-N
InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m1/s1
Molecular Formula | C27H36N2O4 |
Molecular Weight | 452.5857 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
R-enantiomer, AG-EE 624 ZW, is more than 100 fold less active than S-enantiomer as hypoglycaemic compound. It is critical to test and control the content of R(–) isomer in repaglinide to assure the quality of tablet. Repaglinide is an oral medication used for blood sugar control in type 2 diabetes mellitus.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9283692
Rat, Oral: 0.1, 0.3 and 1.0 mg/kg
Rat, Intravenous: 0.1, 1 mg/kg
Route of Administration:
Other
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:26:03 GMT 2023
by
admin
on
Sat Dec 16 09:26:03 GMT 2023
|
Record UNII |
85M30X62FM
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
10479034
Created by
admin on Sat Dec 16 09:26:03 GMT 2023 , Edited by admin on Sat Dec 16 09:26:03 GMT 2023
|
PRIMARY | |||
|
85M30X62FM
Created by
admin on Sat Dec 16 09:26:03 GMT 2023 , Edited by admin on Sat Dec 16 09:26:03 GMT 2023
|
PRIMARY | |||
|
1600868
Created by
admin on Sat Dec 16 09:26:03 GMT 2023 , Edited by admin on Sat Dec 16 09:26:03 GMT 2023
|
PRIMARY | |||
|
147852-26-4
Created by
admin on Sat Dec 16 09:26:03 GMT 2023 , Edited by admin on Sat Dec 16 09:26:03 GMT 2023
|
PRIMARY | |||
|
DTXSID70163818
Created by
admin on Sat Dec 16 09:26:03 GMT 2023 , Edited by admin on Sat Dec 16 09:26:03 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|